LOUIS C BOCK Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for LOUIS C BOCK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of LOUIS C BOCK. LOUIS C BOCK is a Director in SGX PHARMACEUTICALS, INC. ($SGXP) and a Director in Orexigen Therapeutics, Inc. ($OREX).

Address: 950 TOWER LANE, SUITE 700 FOSTER CITY 94404 CA

Companies in which LOUIS C BOCK is an Insider

Orexigen Therapeutics, Inc.

Trading Symbol: OREX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOUIS C BOCK: Director
Holdings: 3,017,445 shares
Current Value: $13,819,898
Latest Transaction: Jul 28 2009
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SGX PHARMACEUTICALS, INC.

Trading Symbol: SGXP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOUIS C BOCK: Director
Holdings: 0 shares
Latest Transaction: Aug 22 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of LOUIS C BOCK

Sentiment: All, OREX, SGXP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 28 2009OREXOrexigen Therapeut ...BOCK LOUIS CDirectorSellP7.50300,0002,250,0003,017,4453.3 M to 3 M (-9.04 %)
May 28 2009OREXOrexigen Therapeut ...BOCK LOUIS CDirectorOption ExerciseA3.1912,50039,87512,500
Aug 22 2008SGXPSGX PHARMACEUTICAL ...BOCK LOUIS CDirectorOption ExerciseD7.2512,50090,6250
Aug 22 2008SGXPSGX PHARMACEUTICAL ...BOCK LOUIS CDirectorOption ExerciseD5.0310,00050,3000
Aug 22 2008SGXPSGX PHARMACEUTICAL ...BOCK LOUIS CDirectorOption ExerciseD1.3510,00013,5000
Aug 22 2008SGXPSGX PHARMACEUTICAL ...BOCK LOUIS CDirectorSellD3.002,546,7477,640,24102.5 M to 0 (-100.00 %)
Jun 12 2008SGXPSGX PHARMACEUTICAL ...BOCK LOUIS CDirectorOption ExerciseA1.3510,00013,50010,000

View all LOUIS C BOCK insider transactions.